A novel anti-interleukin 1-alpha antibody has shown a significant impact on symptoms, and a high level of safety and tolerability in patients with advanced colorectal cancer, according to phase III data.

Source: Advanced colorectal cancer: Anti-in...oves outcomes significantly over placebo


David Cottle

UBB Owner & Administrator